Showing results (151-160 of 332) with videos related to
Sort By:
Pageof 34
Haematologica|December 16, 2017
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and <i>FLT3</i> internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2013
Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysisAmandine Le Bourgeois, Catherine Mohr, Thierry Guillaume, et al.Leukemia|August 21, 2019
Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMTNoga Shem-Tov, Christophe Peczynski, Myriam Labopin, et al.Blood|July 11, 2015
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantationLaurent Pascal, Luciana Tucunduva, Annalisa Ruggeri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 studyFrançoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.Cancers|July 26, 2020
Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute LeukemiaDhon Roméo Makanga, Francesca Da Rin de Lorenzo, Gaëlle David, et al.British Journal of Haematology|September 13, 2021
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMTAvichai Shimoni, Marie Robin, Simona Iacobelli, et al.Bone Marrow Transplantation|June 1, 2019
Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMTAnnalisa Ruggeri, Myriam Labopin, Bipin Savani, et al.Blood Advances|September 15, 2021
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO studyRaynier Devillier, Edouard Forcade, Alice Garnier, et al.Blood Advances|January 9, 2023
Comorbidities in transplant recipients with acute myeloid leukemia receiving low-intensity conditioning regimens: an ALWP EBMT studyJoshua A Fein, Roni Shouval, Jacques-Emmanuel Galimard, et al.Pageof 34